4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-21-069962
Options or other derivatives
- Chief Financial Officer acquired 17,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Dekker C. Jeffrey Chief Financial Officer | 2021-12-14 | Grant or award · Stock Option (right to buy) | +17,700 | 17,700 | D | ||
Loading xslF345X03/doc4.xml…